Trial Profile
Combination of Remifentanil and Flurbiprofen in Sedation and Analgesia for ESWL of Pancreatic Stone
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Feb 2015
Price :
$35
*
At a glance
- Drugs Flurbiprofen (Primary) ; Remifentanil
- Indications Abdominal pain; Pancreatitis
- Focus Therapeutic Use
- 03 Feb 2015 Status changed from recruiting to completed, according to ClincalTrials.gov record.
- 06 Dec 2013 New trial record